ALKBH5 promotes CD8+ T cell infiltration in the CRC microenvironment by inhibiting the NF‐κB pathway and reducing C‐C motif chemokine ligand 5 (CCL5) expression. This evidence concerns the gene CD8A and colorectal carcinoma.